ARCHIVES

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

April 11, 1997

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

Gallo’s Deputy Removed Pending Investigation

January 11, 1991

In Brief: Waxman Now Key House Health Figure; Kennedy Subcommittee Beefed Up with Top Democrats

February 9, 1979

DCPC Planning 10 More Prevention Fellowship Awards

August 14, 1987

Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer

December 27, 2002